The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2019

Filed:

Oct. 10, 2016
Applicant:

Emory University, Atlanta, GA (US);

Inventors:

Ioanna Skountzou, Atlanta, GA (US);

Nicole Brock, McDonough, GA (US);

Elena Vassilieva, Atlanta, GA (US);

Richard Compans, Atlanta, GA (US);

Assignee:

Emory University, Atlanta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61B 17/20 (2006.01); A61K 39/145 (2006.01); A61K 39/12 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 47/22 (2006.01); A61K 9/08 (2006.01); A61K 31/015 (2006.01); A61K 31/122 (2006.01); A61K 31/167 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61B 17/205 (2013.01); A61K 9/0021 (2013.01); A61K 9/08 (2013.01); A61K 31/015 (2013.01); A61K 31/122 (2013.01); A61K 31/167 (2013.01); A61K 39/12 (2013.01); A61K 45/06 (2013.01); A61K 47/22 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55511 (2013.01); C12N 2760/16134 (2013.01);
Abstract

This disclosure relates to methods of immunization comprising administering an effective amount of an immunogenic composition comprising an antigen or vaccine and an adjuvant disclosed herein to a subject in need thereof. In certain embodiments, the adjuvant is 1,8-dihydroxy-9,10-dihydroanthracen-9-one or derivative thereof. In certain embodiments, the adjuvant is N-(3,5-bis-trifluoromethyl-phenyl)-5-chloro-2-hydroxy-benzamide or derivatives thereof. In certain embodiments, the adjuvant is a fullerene or derivatives thereof, e.g., Fullerene-C. In certain embodiments, the disclosure relates to compositions and devices comprising adjuvants disclosed herein.


Find Patent Forward Citations

Loading…